Vibrio vulnificus produces a severe septic shock syndrome in susceptible individuals. Virulence of the bacterium has been closely linked to the presence of a surface-exposed acidic capsular polysaccharide (CPS). To investigate whether CPS plays an additional role in pathogenesis by modulating inflammatory-associated cytokine production, studies were initiated in a mouse model and followed by investigations of cytokine release from human peripheral blood mononuclear cells (PBMCs). Mouse tumor necrosis factor alpha (TNF-␣) could be detected in serum up to 12 h postinoculation in animals challenged with the encapsulated parent strain MO6-24/O. The unencapsulated strain CVD752 was quickly eliminated by the animals, thus preventing a direct association between serum TNF-␣ levels and the presence or absence of the CPS. Purified CPS from MO6-24/O when injected into D-galactosamine-sensitized mice was a more immediate inducer of TNF-␣ than an equivalent quantity of MO6-24/O lipopolysaccharide (LPS). Both V. vulnificus CPS and V. vulnificus LPS induced inflammation-associated cytokine responses from primary human PBMCs in vitro. CPS elicited TNF-␣ from PBMCs in a dose-dependent manner, with maximal induction at 6 to 10 h, and was not inhibited by polymyxin B. Expression of interleukin-6 (IL-6) mRNAs was also induced in the presence of CPS. Interestingly, while adherent PBMCs secreted high levels of TNF-␣ after stimulation with LPS, they secreted little TNF-␣ in response to CPS. These studies provide evidence that V. vulnificus CPS directly stimulates the expression and secretion of proinflammatory cytokines by murine and human cells and suggest that CPS activation of PBMCs operates through a cellular mechanism distinct from that of LPS.
Vibrio vulnificus, a gram-negative bacterium found commonly in the estuarine environment, has been associated with primary septicemia following the consumption of contaminated shellfish. In over 50% of these cases the patient dies of multi-organ failure as a result of a rapidly progressive shock syndrome (5, 12) . Numerous studies have been undertaken to determine the bacterial virulence factors associated with the pathogenesis of this organism. V. vulnificus strains produce a number of extracellular products including hemolytic cytolysin (10) , elastolytic protease (13) , and siderophores (16, 35) which may play a role in disease. Surface structures such as lipopolysaccharide (LPS) (1, 18) and outer membrane proteins (35) have also been investigated.
Presence of a capsular polysaccharide (CPS) has been shown to be essential to the virulence of V. vulnificus. Early observations noted the presence of two colony morphologies in which the opaque (encapsulated) strains were virulent and the naturally occurring translucent variants (minimally encapsulated) were noticeably less virulent in animal models (28, 37) . These observations were further confirmed by Wright et al. (36) using acapsular transposon mutants which were significantly less virulent in mice than the parent strain. As observed with other bacterial species, the capsule of V. vulnificus has been shown to protect the organism from complement-mediated lysis and phagocytosis by macrophages (14, 26) . Antibodies produced to the CPS are protective against challenge with the homologous bacterial strain in both active and passive mouse models (6, 27) , and immune serum has the ability to ''rescue" animals up to 2 h postchallenge (7) . The complete carbohydrate structures of CPS from four V. vulnificus strains have been elucidated, and while the sugar moieties contained in each CPS differ, the four CPS types share the common feature of a three-sugar backbone with a single sugar side chain in their repeating units (22, 23, 23a) .
Septic shock results from the overproduction and dysregulation of the host cytokine response to invading microorganisms. Inflammation-associated cytokines tumor necrosis factor alpha (TNF-␣), interleukin-1 (IL-1), and IL-6 play a pivotal role in the host immune response to infection (24) . In recent years it has been recognized that a wide variety of bacterial products, including LPS, lipoarabinomannans, porins, and CPSs, have the ability to elicit or modulate the release of cytokines from host cells in both in vivo and in vitro models (11) . Since the CPS of V. vulnificus constitutes a major surface antigen which is loosely associated and can be released into the surrounding environment, it is plausible that the polysaccharide may play an additional role in the pathogenesis of this organism.
As a first step toward investigating this question, we sought to determine whether V. vulnificus CPS displayed proinflammatory stimulatory activity. In particular we were interested in ascertaining whether V. vulnificus CPS bears the capacity to stimulate TNF-␣ secretion by host cells, in light of the key role this host cytokine plays in shock syndromes (4).
MATERIALS AND METHODS
Bacterial strains and culture conditions. Encapsulated V. vulnificus parent strain MO6-24/O and capsule-negative TnphoA mutant CVD752 have been described elsewhere (36) . Strains were maintained at Ϫ70°C in Luria (L) broth containing 50% glycerol and were routinely cultured on L agar incubated at 30°C to allow determination of encapsulation by colony morphology (opaque versus translucent). For mouse challenge studies an L broth culture was inoculated from a freshly isolated bacterial colony and cultured overnight at 30°C with shaking. Bacterial cells were collected by centrifugation and washed once with sterile phosphate-buffered saline (PBS). The optical density at 600 nm was determined for each strain, and PBS was added to give an appropriate CFU/milliliter concentration.
Medium and reagents. Bacteriological medium was obtained from Difco (Detroit, Mich.). Tissue culture reagents including RPMI 1640, L-glutamine, sodium pyruvate, HEPES, and penicillin-streptomycin were obtained from GIBCO BRL (Gaithersburg, Md.). Human AB serum, D-galactosamine, and Escherichia coli O55:B5 LPS were obtained from Sigma (St. Louis, Mo.).
CPS and LPS extraction. CPS was extracted and purified from V. vulnificus strain MO6-24/O as previously described (22) . CPS was further purified through detoxi-gel columns (Pierce, Rockford, Ill.) to remove any residual LPS. LPS was extracted and purified by using a modification of the method of Westphal and Jann (34) . The CPS and LPS preparations were tested by the limulus amoebocyte lysate assay (BioWhittaker, Walkersville, Md.) to determine endotoxin levels (endotoxin units [EU]/milligram).
Mouse TNF-␣ studies. For studies investigating TNF-␣ induction by live bacterial cells, C57BL/6 female mice (Charles River, Wilmington, Mass.) were inoculated intraperitoneally (IP) with 3 ϫ 10 6 to 4 ϫ 10 6 CFU per animal of either the encapsulated parent strain MO6-24/O or the acapsular transposon mutant CVD752. For the galactosamine-sensitized model, 10 mg of D-galactosamine was given IP to one side of the animal followed by 100 g of V. vulnificus CPS or LPS IP to the opposite side. At various times postinoculation animals were anesthetized, and blood was collected via cardiac puncture. Serum was collected, transferred to microtubes, and stored at Ϫ70°C until being assayed for TNF-␣.
Preparation of human cells. Whole blood was collected from healthy volunteers into tubes containing anticoagulant citrate dextrose solution (Baxter, McGaw Park, Ill.). Peripheral blood mononuclear cells (PBMCs) were separated on lymphocyte separation medium (LSM; Organon-Teknika Corp., Durham, N.C.) according to the manufacturer's instructions. Residual erythrocytes were removed by osmotic lysis, and the resultant cells were washed in RPMI medium. Adherent cells were prepared by resuspending cells in serum-free culture medium, plating in tissue culture-treated petri dishes (approximately 3 ϫ 10 7 cells/ dish), and allowing cells to adhere at 37°C-5% CO 2 for 45 to 60 min. After incubation, nonadherent cells were removed, and adherent cells were washed twice with RPMI medium and then gently scraped from the plate with a rubber policeman. Cells were routinely enumerated with a hemocytometer, and cell viability was determined by trypan blue dye exclusion. Final resuspension of cells was made in culture medium (RPMI 1640, L-glutamine, Na-pyruvate, penicillinstreptomycin, HEPES, 10% human AB serum), and cells were held on ice until being added to the assay plate.
Cell assays. Assays for determining TNF-␣ levels in supernatants were carried out in 96-well (6 ϫ 10 5 PBMCs/well) flat-bottomed microtiter plates (Corning, Corning, N.Y.), and for experiments resulting in cells for total RNA extraction, assays were carried out in 6-well (10 7 PBMCs/well) flat-bottomed microtiter plates (Corning). CPS, LPS, and polymyxin B sulfate (Sigma) were diluted to test concentrations in culture medium and added to the wells of an assay plate. Prepared PBMCs or adherent cells were added to appropriate wells, and the plates were incubated at 37°C-5% CO 2 . In all experiments culture medium containing no CPS or LPS was included as a negative control. At designated time points, cell supernatants were collected for cytokine analysis by enzyme-linked immunosorbent assay (ELISA) and cells were collected for total RNA extraction. Cell-free culture supernatants were stored at Ϫ20°C until being assayed for TNF-␣ by ELISA.
Quantification of TNF-␣. TNF-␣ levels in both mouse serum and supernatants from human cell assays were determined by the appropriate ELISA (Genzyme, Cambridge, Mass. [mouse TNF-␣]; PharMingen, San Diego, Calif. [human TNF-␣]). Recombinant human TNF-␣ (Genzyme, Cambridge, Mass.) was diluted appropriately in PBS-10% fetal bovine serum for the standard curve.
Reverse transcriptase-PCR-mediated mRNA amplification. Total RNA was purified from PBMCs by using a solution of guanidine isothiocyanate and phenol (TRIZOL; GIBCO BRL) according to the manufacturer's instructions. RNA samples were routinely treated with DNase I (GIBCO BRL) to remove residual contaminating genomic DNA. First-strand cDNA was synthesized from 1 to 5 g of total RNA by using RNase H reverse transcriptase (SuperScript; GIBCO BRL). The PCR was performed on reaction mixtures (25 l) containing approximately 1 l (1 l of a 1:20 dilution for ␤-actin) of cDNA, 0.2 M (each) 5Ј and 3Ј primers, 1ϫ PCR buffer (Promega, Madison, Wis.), 25 mM MgCl 2 (Promega), 10 mM deoxynucleoside triphosphate mix (GIBCO BRL) and 1 U of Taq DNA polymerase (Promega). cDNA and deoxynucleoside triphosphates were separated by a layer of wax (AmpliWax; Perkin-Elmer, Branchburg, N.J.) from the primer and Taq polymerase solution until the first denaturation occurred. Amplification of the cDNA was performed with a thermal cycler (Stratagene, La Jolla, Calif.) under the following cycle conditions: denaturation, 94°C for 45 s; primer annealing, 60°C for 2 min; and DNA strand extension, 72°C for 3 min. A total of 30 cycles of amplification were carried out including a final extension step at 72°C for 7 min. Samples were held at 4°C until visualization of PCR products by agarose gel electrophoresis. PCR products were separated on 2% agarose gels electrophoresed in 0.5ϫ Tris-acetate-electrophoresis buffer, and the gels were stained with ethidium bromide and photographed. Cytokine primers for ␤-actin, TNF-␣, IL-2, gamma interferon, IL-1␤, IL-4, IL-6, IL-10, and IL-12 were synthesized by using previously published sequences (15) .
Statistical analysis. For studies using mice challenged with either the encapsulated parent strain or the unencapsulated isogenic mutant, individual t tests were performed for each time point (1, 2, 3, and 6 h) to compare the mean serum TNF-␣ levels of the two strains. The relationship between antigen concentration and release of TNF-␣ was analyzed by linear regression. The effect of the presence of polymyxin B on TNF-␣ release was evaluated by using Wilcoxon rank sum tests. Differences in the time course of TNF-␣ release for different antigens were analyzed by two-factor analysis of variance. In this analysis, the factor of interest was the interaction between antigen and time, which, if statistically significant, would suggest that the different antigens cause different temporal patterns of TNF-␣ release. Statistical significance was evaluated at the 5% level.
RESULTS
Serum TNF-␣ levels from mice challenged with V. vulnificus parent strain and acapsular transposon mutant. Groups of C57BL/6 mice were challenged with 3 ϫ 10 6 to 4 ϫ 10 6 CFU of either the encapsulated parent strain MO6-24/O or the acapsular mutant CVD752. Sera collected at various time points postchallenge were analyzed for TNF-␣ by ELISA. Induction of serum TNF-␣ levels was rapid for both V. vulnificus strains, with TNF-␣ being detected in serum from 50% (three of six) of animals for CVD752 and 83% (five of six) of animals for MO6-24/O by 2 h postchallenge (Table 1) . However, TNF-␣ levels stimulated by the strains did not differ (P Ͼ 0.05) until 3 h postchallenge (P ϭ 0.02). In what appeared to be a biphasic response to the encapsulated strain, serum TNF-␣ levels dipped following a decrease in bacteremia between 6 b ‫,ء‬ Significantly different from animals inoculated with CVD752 (P ϭ 0.02). Differences in serum TNF-␣ levels were not significant at 1 and 2 h postchallenge. c Values Ͻ35 pg/ml were below the detectable limit of the ELISA. and 9 h, and then as MO6-24/O continued to multiply in the blood, increased levels of TNF-␣ were detected in serum from most animals at 12 h postchallenge (Table 1) . By 24 h five of six animals challenged with the parent strain had died and no serum TNF-␣ was detected in the one surviving animal (data not shown). In contrast, the unencapsulated mutant CVD752 was very quickly eliminated from the animals, and by 3 h postchallenge neither bacteria nor TNF-␣ was detected in the blood. It was, therefore, difficult to establish from these results whether CPS had a direct effect on the induction of TNF-␣ in mice or whether serum TNF-␣ levels were principally a function of bacterial survival in the animals. Serum TNF-␣ levels in galactosamine-sensitized mice challenged with CPS or LPS. Animals challenged with V. vulnificus induced a systemic TNF-␣ response. To further assess the potential role of CPS in this TNF-␣ induction we utilized the D-galactosamine-sensitized mouse model, which induces hepatatoxic effects in the liver and increases the sensitivity of the animals to LPS. Mice were challenged with an equal amount (wt/vol) of either CPS or LPS prepared from strain MO6-24/O. The initial response in animals was higher to the CPS than to the LPS, both in the level of TNF-␣ released and in the number of animals responding to the antigen (Table 2) . At later time points there was no noticeable difference between the responses to the two antigens.
Secretion of TNF-␣ from human PBMCs. Human PBMCs isolated from three to four healthy donors were stimulated with a range of CPS and LPS concentrations from strain MO6-24/O, and TNF-␣ in cell culture supernatants was quantitated by capture ELISA. In all experiments TNF-␣ levels were below the ELISA detectable limit (Ͻ32 pg/ml) in supernatants from cells incubated with culture medium in the absence of CPS or LPS. Both CPS and LPS stimulated TNF-␣ release in a dosedependent manner, with minimum concentrations of 10 to 50 g/ml and 1 to 5 g/ml being required to elicit a response, respectively (Table 3) . In contrast to the in vivo results, V. vulnificus LPS induced higher levels of TNF-␣ from human PBMCs than CPS. Compared with the control E. coli (O55:B5) LPS (10 ng/ml), V. vulnificus CPS and LPS were less efficient at eliciting TNF-␣ from PBMCs (Table 3) . TNF-␣ secretion by human PBMCs after stimulation with V. vulnificus CPS or LPS followed similar time courses (Fig. 1) . Measurable levels of TNF-␣ were detected in supernatants between 1 and 2 h following addition of the antigen, and levels continued to rise over time until maximal levels were measured in supernatants collected at 6 to 10 h (Fig. 1) . In supernatants collected at 24 and 32 h, the TNF-␣ levels remained above baseline (medium control) but had declined for both CPS and LPS, and levels continued to decline until the final sampling point at 48 h (Fig. 1) .
Effect of polymyxin B on CPS-and LPS-induced TNF-␣ secretion by human PBMCs.
The CPS sample used in these studies was shown to contain undetectable levels of endotoxin (Ͻ1 EU/mg of CPS) by limulus amoebocyte lysate analysis. However, as an additional precaution against the possibility that contaminating exogenous endotoxin might impart TNF-␣ stimulatory activity in the CPS preparations, polymyxin B (20 g/ml) was added to the assay, and its effect on the ability of CPS or LPS to elicit a TNF-␣ response was determined. Stimulation of PBMCs with V. vulnificus CPS in the presence of polymyxin B compared with stimulation in the absence of polymyxin B had no effect on the amount of TNF-␣ elicited (Fig.  2) . Addition of polymyxin B caused a small but nonsignificant decrease in the amount of TNF-␣ released in response to V. vulnificus LPS (three of four donors exhibited 38, 45, and 71% inhibition, respectively) and significantly decreased the activity of E. coli LPS (Fig. 2) .
Cytokine mRNA expression in PBMCs stimulated with CPS or LPS. Since TNF-␣ is only one of a number of cytokines involved in modulating septic shock, PBMCs were stimulated with CPS or LPS, and the effects of these antigens on cytokine mRNA expression were determined at 8 h poststimulation when TNF-␣ protein levels were maximal in cell culture supernatants. IL-6 mRNA transcripts were induced in the presence of V. vulnificus CPS and LPS, while E. coli LPS also induced expression of IL-10 mRNAs (Fig. 3) . Due to the presence of detectable TNF-␣ mRNAs from PBMCs in the absence of antigen stimulation (constitutive expression) we were unable to show direct induction of TNF-␣ transcripts (data not shown). Induction of mRNA expression was not observed for 
IL-1␤, IL-2, IL-4, IL-12, or gamma interferon in PBMCs stimulated with CPS or LPS for 8 h (data not shown).
Secretion of TNF-␣ from adherent PBMCs. Monocytes/ macrophages are the predominant cell source of inflammationassociated cytokines. To determine whether monocytes/macrophages were the predominant source of proinflammatory cytokines following CPS stimulation, adherent cells (predominantly monocytes/macrophages) were separated from total PBMCs and stimulated with V. vulnificus CPS. As shown in Table 4 CPS did not stimulate elevated TNF-␣ secretion from adherent PBMCs but readily elicited TNF-␣ secretion from total PBMCs containing an equivalent number of adherent cells from the same donor. E. coli O55:B5 LPS, on the other hand, elicited similar levels of TNF-␣ by both adherent PBMCs and total PBMCs.
DISCUSSION
Studies of bacterial septic shock in the past have generally focused on LPS, a potent mediator of host pyrogenic responses. Nonetheless, bacterial products other than LPS have been shown to induce inflammation-associated cytokines leading to the final common pathways in shock as those initiated by LPS (11) . V. vulnificus is an encapsulated, gram-negative bacterium capable of causing an aggressive septic shock syndrome, but little is known about the bacterial factors involved in the induction of shock. Unlike classical gram-negative enterobacterial LPS-induced shock, the LPS from V. vulnificus is reported to be less pyrogenic (18) , and thus it is unclear as to whether this molecule alone is responsible for the rapid induction of septic shock that is typically seen with this pathogen. The CPS of V. vulnificus is a major surface antigen and an important virulence determinant, enabling the organism to resist phagocytosis and host serum killing activity (14, 26, 28) . The central hypothesis of our research is that CPS plays an additional role in pathogenesis by serving as a biologic response modifier or "modulin" (11) , thus modulating (increasing or decreasing) host cytokine responses and accelerating the events that lead to shock. Host cells that encounter V. vulnificus would first be exposed to the polysaccharide capsular material, either cell associated or cell free.
To investigate this hypothesis we have explored the ability of cell surface molecules from V. vulnificus such as CPS and LPS to mediate host cytokine responses. In the animal model encapsulation was shown to be necessary for bacterial survival, and the presence of bacteria in the blood (encapsulated or unencapsulated strains) paralleled induction of inflammatory cytokines. Purified CPS was a more immediate, and on a weight/volume basis, more active inducer of TNF-␣ than LPS in the D-galactosamine-sensitized mouse model. This is interesting in light of the damage to hepatocytes caused by the administration of D-galactosamine and the important role of liver damage in the susceptibility of some individuals to V. vulnificus septicemia and shock (5, 12) . At relatively high concentrations neither molecule caused lethality in the D-galactosamine-sensitized mouse model as has been described for enterobacterial LPS. This observation regarding V. vulnificus is consistent with data reported by McPherson et al. (18) who showed that LPS from V. vulnificus C7184 was not lethal in mice without galactosamine treatment even at concentrations of 88 mg/kg. This group also showed that the LPS of V. vulnificus C7184 may be rough (i.e., lack O side chains) and that the fatty acid profiles of lipid A were different from those of enterobacteriaceae and other vibrios (1, 2). The differences in lipid A structure may directly affect the endotoxic activity of this LPS and may also account for the inability of polymyxin B to effectively inhibit the induction of TNF-␣ by MO6-24/O LPS in our PBMC studies. We have also been unable to visualize the characteristic "ladders" indicative of a smooth LPS by immunoblot analysis of MO6-24/O LPS (data not shown).
Human PBMCs responded to both V. vulnificus CPS and LPS as judged by the secretion of TNF-␣ and induced mRNA expression of inflammation-associated cytokines, with LPS inducing slightly higher levels of TNF-␣. Additionally, on a weight/volume basis both the CPS and LPS from V. vulnificus were considerably less active in eliciting TNF-␣ than LPS from E. coli O55:B5. Our interpretation of these results is tempered since we do not presently know the active moiety on the CPS molecule and large amounts of CPS were necessary for the elicitation of TNF-␣ secretion by PBMCs. However, the concentrations used in the present study and the resultant TNF-␣ levels are comparable to those reported for other bacterial CPSs (3, 30) .
The mechanisms by which CPSs interact with host cells was not the topic of this study, and they are not clearly understood at present. Espevik et al. (9) reported that uronic acid polymers bind to CD14 in a manner similar to that of LPS. It has also been suggested that T-independent type 2 antigens such as bacterial CPS activate cells by cross-linking multiple cell surface molecules, thereby inducing signal transduction events that result in cellular activation and differentiation (19) . It is of interest, therefore, that the adherent cell PBMC fraction responded poorly to V. vulnificus CPS in contrast to the response to enterobacterial LPS. This observation suggested that accessory cells and/or their products were necessary for cytokine induction by CPS.
It remains to be determined whether the interaction(s) between bacterial CPS and host cells was due to specific structural motifs or reflects a nonspecific response to large molecules with repeating structures. Previously reported studies with other bacterial CPSs may provide clues (17, 29, 30, 32) . The ability of the Bacteroides fragilis capsule polysaccharide complex (CPC) to cause abscesses was shown to be due to a specific charge motif of the complex (33) , and T lymphocytes have been shown to play an important role both in abscess formation and the induction of antibodies to the capsule (20, 25) . This is of interest because B. fragilis CPC contains quinovosamine and other sugars that are also present in the V. vulnificus MO6-24/O CPS (21) , and polyclonal antiserum raised against MO6-24/O CPS also shows reactivity with the B. fragilis CPC (10a). Rhamnose is thought to be important in cellular responses to polysaccharides from Streptococcus mutans (31) . In a recent survey of 120 V. vulnificus strains from both clinical specimens and the environment, rhamnose was found in the capsular material from 73% of isolates (5a).
While CPS and LPS from V. vulnificus are clearly not as pyrogenic as counterpart enterobacterial endotoxins, their potential roles in the modulation of the host cytokine response should not be discounted. The results of the present study corroborate the findings of Espat et al. (8) that V. vulnificus can induce a septic shock-like syndrome in mice and that serum TNF-␣ levels parallel the degree of bacteremia. V. vulnificus CPS, as a major surface antigen, clearly has the potential to interact with host cells, as shown by its ability to induce cytokines in mice and from human PBMCs. The mechanism of these interactions and their role in V. vulnificus pathogenesis have yet to be completely elucidated and continue to be the focus of our current research. a Adherent cells were isolated on the basis of their adherence to plastic in serum-free culture medium.
b Significantly different from TNF-␣ level secreted by an equivalent number of adherent cells. Data presented are the means Ϯ standard deviations of triplicate wells from assays performed with cells from four donors.
